↓ Skip to main content

A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer

Overview of attention for article published in Oncogene, June 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer
Published in
Oncogene, June 2016
DOI 10.1038/onc.2016.185
Pubmed ID
Authors

L A Selth, R Das, S L Townley, I Coutinho, A R Hanson, M M Centenera, N Stylianou, K Sweeney, C Soekmadji, L Jovanovic, C C Nelson, A Zoubeidi, L M Butler, G J Goodall, B G Hollier, P A Gregory, W D Tilley

Abstract

MicroRNA-375 (miR-375) is frequently elevated in prostate tumors and cell-free fractions of patient blood, but its role in genesis and progression of prostate cancer is poorly understood. In this study, we demonstrated that miR-375 is inversely correlated with epithelial-mesenchymal transition signatures (EMT) in clinical samples and can drive mesenchymal-epithelial transition (MET) in model systems. Indeed, miR-375 potently inhibited invasion and migration of multiple prostate cancer lines. The transcription factor YAP1 was found to be a direct target of miR-375 in prostate cancer. Knockdown of YAP1 phenocopied miR-375 overexpression, and overexpression of YAP1 rescued anti-invasive effects mediated by miR-375. Furthermore, transcription of the miR-375 gene was shown to be directly repressed by the EMT transcription factor, ZEB1. Analysis of multiple patient cohorts provided evidence for this ZEB1-miR-375-YAP1 regulatory circuit in clinical samples. Despite its anti-invasive and anti-EMT capacities, plasma miR-375 was found to be correlated with circulating tumor cells in men with metastatic disease. Collectively, this study provides new insight into the function of miR-375 in prostate cancer, and more broadly identifies a novel pathway controlling epithelial plasticity and tumor cell invasion in this disease.Oncogene advance online publication, 6 June 2016; doi:10.1038/onc.2016.185.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 22%
Researcher 13 16%
Student > Master 8 10%
Student > Bachelor 7 9%
Professor > Associate Professor 5 6%
Other 17 22%
Unknown 12 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 29 37%
Medicine and Dentistry 15 19%
Agricultural and Biological Sciences 11 14%
Chemistry 2 3%
Social Sciences 2 3%
Other 4 5%
Unknown 16 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2016.
All research outputs
#2,713,029
of 22,876,619 outputs
Outputs from Oncogene
#888
of 10,655 outputs
Outputs of similar age
#49,636
of 340,764 outputs
Outputs of similar age from Oncogene
#32
of 124 outputs
Altmetric has tracked 22,876,619 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,655 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,764 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.